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Background: In addition to TCR and costimulatory signals, 
cytokine signals are required for the differentiation of acti-
vated CD8 T cells into memory T cells and their survival. 
Previously, we have shown that IL-12 priming during initial 
antigenic stimulation significantly enhanced the survival of 
activated CD8 T cells and increased the memory cell 
population. In the present study, we analyzed the mecha-
nisms by which IL-12 priming contributes to activation and 
survival of CD8 T cells. Methods: We observed dramatically 
decreased expression of CD43 in activated CD8 T cells by 
IL-12 priming. We purified CD43
lo and CD43
hi cells after 
IL-12 priming and analyzed the function and survival of each 
population both in vivo and in vitro. Results: Compared to 
CD43
hi effector cells, CD43
lo effector CD8 T cells exhibited 
reduced cytolytic activity and lower granzyme B expression 
but showed increased survival. CD43
lo effector CD8 T cells 
also showed increased in vivo expansion after adoptive 
transfer and antigen challenge. The enhanced survival of 
CD43
lo CD8 T cells was also partly associated with CD62L 
expression. Conclusion: We suggest that CD43 expression 
regulated by IL-12 priming plays an important role in differ-
entiation and survival of CD8 T cells.
[Immune Network 2010;10(5):153-163]
INTRODUCTION
T cells can be classified into three separate classes: naïve, ef-
fector and memory. Antigen-specific naïve CD8 T cells exist 
a t  v e r y  l o w  f r e q u e n c i e s .  B u t  d u r i n g  a n  i m m u n e  r e s p o n s e ,  
these cells undergo massive clonal expansion and finally form 
memory T cells. Memory T cells are well suited to combat 
pathogens because they are present at higher numbers than 
naïve CD8 T cells, persist for extended periods due to anti-
gen-independent  homeostatic  turnover,  and  can  mediate  a 
substantially  accelerated  recall  response  to  secondary  in-
fection (1,2). Thus, many efforts have been made to elucidate 
how  to  efficiently  elicit  greater  numbers  and  longer-lived 
m e m o r y  T  c e l l s .
    It has been proposed that a brief period of antigen encoun-
ter can commit naïve cells to a program of effector and mem-
ory differentiation (2-6). However, it has been shown that the 
duration and strength of antigenic and costimulatory signals 
can also regulate the fate of developing effector and memory 
T cells (7,8). In this case, memory cells are proposed to dif-
ferentiate from naïve cells by virtue of qualitative and quanti-
tative differences in the perceived signal. In particular, early 
inflammatory cytokine signals known as “third signal” have 
been shown to be involved in the induction of effector re-
sponse and the generation and maintenance of effector and 
memory cells (9-14). However, the exact mechanisms regulat-
ing  the  fate  of  activated  T  cells  still  remain  undefined. 
Previously,  we  showed  that  IL-12  priming  during  antigenic 
stimulation dramatically increased the population of effector 
and memory CD8 T cells mainly by preventing activation-in-
duced cell death (9), suggesting that development of memory 
c e l l s  c o u l d  b e  r e g u l a t e d  b y  e a r l y  I L - 1 2  s i g n a l i n g .
    CD43 is a cell-surface sialoglycoprotein expressed by a va-
riety of hematopoietically derived cells, including T lympho-
cytes (15-17). Posttranslational modifications result in two gly-The Role of CD43 in CD8 T-cell Survival
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coforms of CD43: 115 kDa and 130 kDa. The mAb 1B11 rec-
ognizes  the  activation-associated  glycoform  (130  kDa)  of 
CD43 (18,19). The 130 kDa glycoform of CD43 bears two core 
O-glycans, an oligosaccharide structure that can be created by 
the action of the core β-1-6-N-acetylglucosaminyltransferase. 
1B11  binding  is  low  on  naïve  CD8
＋ T  c e l l s  a n d  h i g h  o n  
Ag-specific  effector  CD8
＋  T  cells,  and  becomes  reduced 
again  on  Ag-specific  memory  CD8
＋  T  cells  (20).  Although 
CD43  is  one  of  the  most  abundant  T  cell  surface  glyco-
proteins, its function is still debated. It has been suggested 
to have anti-adhesive functions in T cell trafficking and hom-
ing  (21-23).  Some  evidence  suggests  that  CD43  provides  a 
highly charged barrier to cell-cell interaction (24,25). A topo-
logical  view  of  T  cell-APC  interactions  has  been  proposed 
(26), suggesting that CD43 may be a cell surface regulatory 
protein that damps T cell responses by its physical presence 
(27).  This  hypothesis  could  be  supported  by  the  fact  that 
CD43 is excluded from the immunological synapse during T 
cell  activation  (27-29).  Addit i o n a l l y ,  C D 4 3  h a s  b e e n  a l s o  
shown  to  play  a  role  in  T  cell  activation.  Some  studies 
showed that CD43 transduces multiple activating signals that 
ultimately  induce  expression  of  certain  genes  during  T  cell 
activation (30-32) and plays a costimulatory role in vitro and 
in  vivo  (33-35).  In  contrast,  other  groups  have  shown  that 
CD43
−/−T  cells  are  hyperproliferative  in  vitro  (21,36).
    In  the  present  study,  we  analyzed  the  mechanisms  by 
which IL-12 priming contributes to the activation and the en-
hanced survival of CD8
＋ T cells and observed dramatically 
decreased  expression  of  CD43  in  activated  CD8
＋ T  c e l l s  
primed by IL-12. To determine the role of CD43 expression 
in the survival of activated CD8 T cells, we purified CD43
lo 
and CD43
hi cells after IL-12 priming and analyzed the function 
and survival of each population. CD43
lo effector CD8
＋ T cells 
exhibited  reduced  cytolytic  activity,  lower  granzyme  B  ex-
pression  and  reduced  IFN-γ production  but  showed  sig-
nificantly increased survival  both  in vivo a nd  in vitro com-
pared to CD43
hi cells. These CD43
lo effector CD8 T cells are 
associated with higher expression of CD62L than CD43
hi ef-
fector  CD8  T  cells.  Together,  these  results  suggest  that  the 
expression  of  the  activated  form  of  CD43  is  significantly 
down-regulated by IL-12 priming, which gives rise to a prefer-
ential, long-lived CD8
＋ T cell memory population that is part-
l y  a s s o c i a t e d  w i t h  t h e  l e v e l s  o f  C D 6 2 L  e x p r e s s i o n .
MATERIALS AND METHODS
Mice
Female C57BL/6 mice were purchased from The Charles River 
Japan (Shizuoka, Japan). OT-I TCR transgenic mice were pur-
chased  from The Jackson Laboratory (Bar Harbor,  ME). All 
mice  were  housed  under  specific  pathogen-free  conditions 
and  were  used  between  6  and  12  weeks  of  age  following 
institutional  animal  care  and  use  committee  protocols.
Antibodies and reagents
All antibodies were purchased from BD Bioscience-Pharmin-
gen  (San  Diego,  CA),  unless  specified  otherwise.  Recombi-
nant human IL-2 and murine IL-12 were purchased from R&D 
Systems (Minneapolis, MN). CD8α
＋ T cell isolation kits and 
anti-PE  microbeads  were  obtained  from  Miltenyi  Biotec 
(Auburn,  CA).
In vitro T cell activation, isolation, adoptive transfer 
and infection
Spleen cells from OT-I TCR transgenic mice were stimulated 
with  OVA257-264 p ep ti de  (S II N F EK L ; re fe rr ed  t o a s O VA p) i n 
complete IMDM supplemented with 2 mM L-glutamine, 50μM 
2-ME, and 10 U/ml human rIL-2 in the presence of rIL-12 (5 
ng/ml). After in vitro stimulation, the CD8
＋ T cells were puri-
f i e d  b y  n e g a t i v e  s e l e c t i o n  u s i n g  m a g n e t i c  b e a d  s e p a r a t i o n  
(MACS) according to the manufacturer’s instructions (Miltenyi 
Biotec). CD43
lo and CD43
hi cells were then purified by neg-
ative selection and positive selection using anti-CD43-PE and 
anti-PE microbeads. Purified CD43
hi and CD43
lo CD8
＋ T cells 
(2×10
6 in 200μl of PBS) were transferred into naïve C57BL/6 
mice via tail vein injection. For recall response, 1×10
5 puri-
fied CD43
hi and CD43
lo CD8
＋ T cells in 200μl of PBS were 
transferred  into  naïve  C57BL/6  mice  via  tail  vein  injection, 
and at day 1 after transfer, the mice were intranasally chal-
lenged with 2×10
7 pfu of recombinant adenovirus expressing 
OVA  (rAd/OVA).
Surface staining, intracellular staining, and flow 
cytometric analysis
In order to count the total number of donor T cells, recipient 
mice  were  sacrificed,  and  cells  from  spleens  were  re-
suspended in FACS buffer (1% FBS, 0.03% sodium azide in 
PBS) at a concentration of 1×10
7 cells/ml. A total of 100μl 
of  these  cells  (1×10
6  cells)  was  stained  for  CD8  (clone 
53-6.7),  CD43  (1B11),  CD62L  (MEL-14)  or  CD127  (A7R34), The Role of CD43 in CD8 T-cell Survival
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and  samples  were  acquired  on  FACS  Calibur
TM ( B D  
Biosciences, San Jose, CA). PE or APC-conjugated OVA-spe-
cific  MHC  I  tetramer,  Kb/OVA-Tet,  was  produced  as  de-
scribed elsewhere (9), and the optimal concentration was de-
termined  by  titration.  Cells were stained  for  40  min at  4
oC 
using fluorochrome-conjugated Abs and Kb/OVA-Tet, wash-
ed,  and  fixed  in  PBS  containing  2%  formaldehyde  before 
analysis by flow cytometry. For intracellular staining, purified 
CD43
hi and CD43
lo cells were co-cultured at 37
oC for 5 h with 
OVA  peptide  and  BFA.  After  culture,  the  cells  were  first 
stained  for  surface  markers,  then  washed,  fixed  and  per-
meabilized  with  FACS  buffer  containing  0.5%  saponin 
(Sigma-Aldrich,  Seoul,  Korea).  The  cells  were  then  stained 
with  anti-IFN-γ (XMG1.2).  For  granzyme  B  staining,  cells 
were  fixed  and  permeabilized  with  FACS  buffer  containing 
0.5% saponin after surface marker staining. Cells were stained 
with anti-granzyme B (GB12) or isotype control antibody con-
jugated to PE (Caltag Laboratories). Gates were set on lym-
phocytes by forward and side scatter profiles, and the data 
were  analyzed  using  CellQuest
TM P r o  ( B D  B i o s c i e n c e s ) ,  
FlowJo
TM s o f t w a r e  ( W i n d o w s  v e r s i o n  5 . 7 . 2 ,  T r e e S t a r ,  S a n  
Carlos, CA), and WinMDI version 2.8 software (The Scripps 
Research  Institute,  La  Jolla,  CA).
Detection of apoptotic death
Apoptosis  of  in  vitro a c t i v a t e d  T  c e l l s  w a s  d e t e r m i n e d  b y  
Annexin V and 7-amino-actinomycin D (7-AAD) staining, as 
recommended  by  the  manufacturer  (BD  Bioscience,  San 
Diego, CA). In brief, purified CD43
hi and CD43
lo CD8 T cells 
were seeded in 24-well flat-bottom plates (1×10
6 cells/well) 
with IL-2 in 2 ml of complete IMDM. At the indicated time 
points, these cells were washed, resuspended in Annexin V 
binding  buffer  at  a  concentration  of  1×10
6  cells/ml,  in-
cubated with Annexin V-FITC and 7-AAD, and analyzed by 
flow  cytometry.
Cell-mediated cytotoxicity assay
MACS-separated CD43
lo and CD43
hi effector cells were used 
i n  t h e  C T L  a s s a y  in  vitro.  Peptide-pulsed  EL4  target  cells 
(1×10
4/well) were added to serial dilutions of effector cells 
(prepared as described above) in 96-well round-bottom plates 
at E：T cell ratio of 1：1 to 20：1. After 4 h at 37
oC, cytotox-
icity was quantified by measurement of cytosolic lactate de-
hydrogenase (LDH) in the culture supernatant (n=3) using cy-
totoxicity detection kit (Roche Diagnostics). Specific lysis for 
each  E：T  c e l l  r a t i o  w a s  e x p r e s s e d  a s :  s p e c i f i c  l y s i s = [ ( e x -
perimental release)−(spontaneous release)/(target maximum
−target spontaneous release)]. Spontaneous LDH release in 
the absence of CTL was ＜10% of the maximal cellular re-
lease by detergent lysis. All experimental procedures and as-
says were performed two or more times with similar results.
Statistical analysis
Comparisons  between  groups  were  analyzed  using  a 
Student’s t-test (SAS8.2 software). Significance was accepted 
a s  a  v a l u e  o f  p ＜0.05.
RESULTS
CD43 expression regulated by initial IL-12 priming dur-
ing primary CD8
＋ T cell stimulation
Previously we showed that IL-12 priming during initial anti-
genic stimulation significantly enhanced the survival of acti-
vated CD8 T cells and increased the memory cell population 
after adoptive transfer (9). Recent studies have suggested that 
activation markers, such as CD43 and CD27, define distinct 
subpopulations of memory CD8
＋ T cells that differ in their 
capacities  to  mount  recall  responses  (20,37).  To  determine 
whether  IL-12  priming  induces  any  changes  in  CD43  ex-
pression during in vitro stimulation, we analyzed CD43 ex-
pression  on  OT-I  cells  stimulated  with  cognate  OVA 
(SIINFEKL) in the presence or absence of IL-12. The level of 
CD43 and CD44 on naïve cells was low, but after antigenic 
stimulation, most OT-I cells expressed CD44
hi activated phe-
notype  and  some  of  them  started  to  express  CD43  on  day 
1 (Fig. 1). There was no significant difference in the CD43 
expression between non-primed and IL-12-primed cells dur-
ing this period. However, beginning on day 3, IL-12-primed 
cells showed a relatively lower proportion of CD43-positive 
cells  than  non-primed  cells,  and  this  selective  down-regu-
lation of CD43 by a subpopulation of effector cells was ob-
served  clearly  on  days 3,  5 and 7  (Fig.  1A). To determine 
whether CD43 is associated with the typical characteristics of 
memory  precursors,  we  assessed  CD43  expression  together 
w i t h  o t h e r  a c t i v a t i o n  m a r k e r s  s u c h  a s  C D 1 2 7  ( 3 8 ) ,  K L R G - 1  
(39)  and  CD62L  (40,41)  that  identify  memory  precursors. 
There was no significant difference in the CD127 expression 
between CD43
hi cells and CD43
lo  cells (Fig. 1B). However, 
CD43
lo cells showed a relatively higher expression of CD62L 
than CD43
hi cells (Fig. 1B). These data suggest that IL-12 pri-
ming  during  antigenic  stimulation  induced  lower  CD43  ex-
pression than in non-primed cells and that this CD43
lo pheno-The Role of CD43 in CD8 T-cell Survival
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Figure 1. CD43 expression is regulated by initial IL-12 priming during primary CD8 T-cell stimulation. (A) OT-I TCR transgenic cells were stimulated
with the OVA peptide (OVAp) in the presence or absence of IL-12. On days 1, 3 and 7, cells were harvested, stained with anti-CD8α, CD44, 
and CD43, and analyzed by flow cytometry. (B) OT-I cells were stimulated with OVA peptide in the presence of IL-12 (5 ng/ml), and on day 
7, cells were harvested, stained with anti-CD8α, CD43 and CD127, CD62L or KLRG1, and analyzed by flow cytometry. Histograms show the 
expression levels of CD127, CD62L or KLRG1 in the gated CD43
hi and CD43
lo populations and are shown as the mean±SD. The results shown 
are representative of three independent experiments with similar results. Filled histogram, CD43
hi; open histogram, CD43
lo.
t y p e  a m o n g  a c t i v a t e d  T  c e l l s  m a y  b e  a s s o c i a t e d  w i t h  e n -
h a n c e d  s u r v i v a l  o f  a c t i v a t e d  C D 8  T  c e l l s .
Enhanced survival of CD43
lo cells induced by IL-12
CD43 is one of the most abundant T cell surface glycopro-
teins.  But  the  function  of  CD43  as  a  regulatory  protein  in 
T-cell activation remains unclear. To define the role of CD43 
down-regulation by IL-12 priming, we analyzed the survival 
potential of IL-12-primed CD43
hi and CD43
lo CD8 T cells by 
sorting  the  two  populations  by  MACS  and  then  adoptively 
transferring equal numbers into B6 recipient mice (Fig. 2A). 
We analyzed the “take” of donor cells in recipient mice at 
various time points after adoptive transfer. At all time points, 
∼1.5-2-fold higher levels of CD43
lo donor cells were detect-
able in the peripheral blood (Fig. 2B). Some studies suggest 
t h a t  C D 4 3  p l a y s  a  r o l e  i n  t h e  t r a f f i c k i n g  o f  T  c e l l s  t o  s i t e s 
of inflammation (23,42). In addition, a study using CD43-defi-
cient mouse showed that CD43 negatively regulates T lym-
phocyte homing to secondary lymphoid organ (22). Thus, it 
was  possible that the  higher level of CD43
lo donor cells in 
the  blood  was  caused  by  differential  homing  to  lymphoid 
organs. We therefore examined the trafficking of CD43
hi and 
CD43
lo  donor  CD8  T  cells  to  the  lymphoid  organs  and 
non-lymphoid  organs  in  the  recipient  mice.  At  day  7  after 
adoptive transfer, CD43
lo donor cells gave rise to 2-fold high-
er percentages of engraftment in all lymphoid organs exam-
ined such as spleen and mesenteric and inguinal lymph no-
des and 1.5-fold higher percentages in non-lymphoid organs The Role of CD43 in CD8 T-cell Survival
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Figure 2. CD43
lo cells induced by initial IL-12 priming increase their survival rate in vivo, and enhanced survival of CD43
lo cells is not due 
to differential trafficking of transferred cells to various organs. (A) For adoptive transfer experiments, the splenocytes from OT-I TCR transgenic
mice were stimulated with the peptide in the presence of IL-12 for 7 days. CD8
＋CD43
hi and CD8
＋CD43
lo cells were MACS-purified and 2×10
6
cells were i.v. injected into normal C57BL/6 mice. (B) After 3, 10, 17, 34, 45 and 56 days, donor OT-I cells in the blood of recipient mice
were identified by CD8α, K
b/OVA-Tet and CD43 staining. (C) On day 7, the frequency of donor OT-I cells in lymphoid and non-lymphoid
organs of the recipient mice were measured. The results shown are derived from spleens of 5 mice for each group and are representative of 
three independent experiments with similar results. The Role of CD43 in CD8 T-cell Survival
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Figure 3. Attenuation of apoptosis in CD43
lo population. Spleen cell 
suspensions from naïve OT-I mice were cultured for 7 days with 100
nM OVAp in the presence of IL-12. Then, activated OT-I cells were 
MACS-purified and rested for 3 additional days without any stimulant
and with IL-2. At the indicated time points, the cells were harvested
and apoptotic cell death was determined by Annexin V and 7-AAD
double-staining. The samples were assayed in triplicate and the error
bars represent the SD values of the mean.
such as lung and liver (Fig. 2C). These data exclude the pos-
sibility that increased frequency of CD43
lo donor cells in the 
peripheral blood was due to differential trafficking to various 
organs.
    Next,  we  investigated  whether  the  phenotypic  distinction 
of activated CD8 T cells by CD43 affected the susceptibility 
to  apoptosis.  To  this  end,  activated  OT-I  cells  were  sorted 
to CD43
hi and CD43
lo cells and each subset was rested with 
IL-2 and monitored for apoptotic cell death at various time 
points  (Fig. 3).  CD43
lo T c e lls  sh o we d  a s im ila r d ea th  r at e 
to CD43
hi T cells by 48 h into the resting period, but exhibited 
a significant reduction in apoptotic death by 72 h (p＜0.001). 
The proliferation of CD43
lo effector cells was similar to that 
of CD43
hi effector cells (data not shown). These results were 
consistent  with  the  report  that  CD43
−/− m i c e  s h o w e d  d e -
creased death of Ag-specific CD8 T cells (35). Taken together, 
our results indicate that the phenotypic change in CD43 ex-
pression induced by IL-12 was associated with reduced cell 
death and the subsequent enhanced survival of effector and 
memory  CD8  T  cells.
Functional difference between CD43
lo and CD43
hi 
cells induced by initial IL-12 priming
As previously stated, the reported positive and negative roles 
o f  C D 4 3  i n  T  c e l l s  a r e  i n e v i t a b l y  o p p o s e d  t o  e a c h  o t h e r .  
Thus, we investigated whether the CD43
lo and CD43
hi T cell 
subsets exhibited any difference in effector functions. To this 
end, the subsets of CD43
hi and CD43
lo cells were sorted after 
antigenic stimulation in the presence of IL-12, and granzyme 
B expression and killing activity were measured (Fig. 4). A 
comparison of these effector properties between CD43
lo and 
CD43
hi T  c e l l s  d e m o n s t r a t e d  t h a t  C D 4 3
lo C D 8  T  c e l l s  c o n -
tained less granzyme B than CD43
hi CD8 T cells (Fig. 4A), 
and exhibited significantly less killing of OVA peptide-pulsed 
targets (Fig. 4B). These results were consistent with the re-
port that CD43 up-regulation shows a strong correlation with 
t h e  a c q u i s i t i o n  o f  e f f e c t o r  f u n c t i o n  ( 2 0 ) .  I t  i s  p o s s i b l e  t h a t  
CD43  expression  affects  functional  avidity  of  CD8  T  cells 
since CD43 can provide a charge barrier based on the topo-
logical view of cell-cell interactions (24). It is reported that 
TCR avidity of CD8 T cells to peptide/MHC complex corre-
lates with ex vivo cytotoxicity and IFN-γ secretion (43). So, 
we  investigated  whether  CD43
lo a n d  C D 4 3
hi p h e n o t y p e  a f -
fected the functional avidity of OVA-specific effector CD8 T 
cells  by  measuring  dose-responsive  IFN-γ  production. 
CD43
hi effector cells exhibited higher IFN-γ expression than 
CD43
lo effector cells in all peptide concentrations used (Fig. 
4C). But when the data are normalized to % maximum re-
sponse,  dose-responsive  IFN-γ production  of  CD43
hi a n d  
CD43
lo effector cells was comparable (Fig. 4D). This indicates 
that functional avidity of CD43
hi effector cells and CD43
lo ef-
fector cells was similar. Together, these results suggest that 
the  CD43
lo p h e n o t y p e  i n d u c e d  b y  I L - 1 2  p r i m i n g  w a s  a s s o -
ciated with lower granzyme B expression, killing activity and 
IFN-γ secretion  but  not  with  TCR  avidity.
    One of the functional memory properties is recall response 
to the same antigen. So, we next examined recall responses 
of adoptively transferred CD43
lo and CD43
hi populations by 
challenging Ag. To test recall proliferation of memory cells 
generated from CD43
hi and CD43
lo donor cells, we adoptively 
transferred equal numbers of sorted CD43
hi and CD43
lo CD8 
T cells into naïve mice and challenged them with recombi-
nant adenovirus expressing OVA (rAd/OVA) 1 day after adop-
tive  transfer.  We  picked  this  early  time  point  of  challenge 
since CD43
hi and CD43
lo subsets displayed differential survival 
rates even a few days after transfer. We challenged mice with 
the  rAd/OVA  virus  intranasally b e c a u s e  t h e  d i s t r i b u t i o n  o f  
CD43
lo  and  CD43
hi d o n o r  T  c e l l s  i n  t h e  l u n g  t i s s u e s  w a s  
similar. Most of the CD8 T cells detected in the lungs at the 
peak (day 5 after challenge) were donor OT-I cells, and the 
number of OVA/Tet
＋ cells among lymphocyte-gated mono-
nuclear  cells  were  3∼5  fold  higher  in  mice  that  received 
CD43
lo cells than in mice that received the equal number of The Role of CD43 in CD8 T-cell Survival
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Figure 4. Decreased cytolytic functions in CD43
lo population. Spleen cell suspensions from naïve OT-I mice were cultured for 7 days with 100 
nM OVAp in the presence of IL-12. Then, activated OT-I cells were MACS-sorted into CD8
＋CD43
hi and CD8
＋CD43
lo populations. (A) The levels
of granzyme B in each cell population were determined by intracellular staining. Histograms show the expression of granzyme B in the gated
CD43
hi and CD43
lo subsets and are shown as the mean±SD. The results shown are representative of three independent experiments with similar
results. Filled histogram, CD43
lo; open green histogram, CD43
hi. (B) Peptide-pulsed EL4 target cells (1×10
4/well) were added to serial dilutions 
of effector cells (prepared as described above) in 96-well round-bottom plates at E：T ratio of 1：1 to 20：1. After 4 h at 37
oC, cytotoxicity
was quantified by measurement of cytosolic lactate dehydrogenase (LDH) in the culture supernatant (n=3) using a cytotoxicity detection kit. 
All experimental procedures and assays were performed two or more times, with similar results. (C) IFN-γ production of purified CD43
hi and 
CD43
lo cells was assessed by intracellular IFN-γ staining following 5 h stimulation with 1 pM∼1μM OVAp. (D) Data for functional avidity
of purified CD43
hi and CD43
lo cells have been normalized to equate the maximum response obtained after stimulation with the OVAp used 
to establish the line to 100%.
CD43
hi cells (Fig. 5). These results are consistent with the re-
port that CD43
lo CD8 T cells mediate stronger recall responses 
than  CD43
hi c e l l s  ( 3 7 ) .
Enhanced survival of CD43
lo CD8 T cells partly 
associated with CD62L expression
As shown in Fig. 1B, CD43
lo cells showed a relatively higher 
expression  of  CD62L  than  CD43
hi c e l l s .  H i g h  C D 6 2 L  e x -
pression  among  CD8  T  cell  memory  population  has  been 
shown to be a phenotypic characteristic of the central memo-
ry subset (44). To determine whether the higher expression 
of CD62L was involved in the enhanced survival of CD43
lo 
cells,  we  analyzed  the  memory  potential  of  IL-12-primed 
CD62L
hi and CD62L
lo CD8 T cells by MACS purification and 
a subsequent adoptive transfer experiment. After sorting, the 
ratio of CD43
hi：CD43
lo cells among CD62L
hi population was The Role of CD43 in CD8 T-cell Survival
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Figure 5. Recall response of CD43
lo population is superior to that of CD43
hi population. For recall response, the splenocytes from OT-I TCR
transgenic mice were stimulated with the antigenic peptide (OVAp) in the presence of IL-12 for 7 days. Then, CD8
＋CD43
hi and CD8
＋CD43
lo
cells were separated by MACS. 1×10
5 purified CD43
hi and CD43
lo CD8
＋ T cells in 200μl of PBS were transferred into naïve C57BL/6 mice
via tail vein injection and then 1 day after transfer, the mice were intranasally challenged with 2×10
7 pfu of recombinant adenovirus expressing
OVA (rAd/OVA).
approximately  1：9  while  that  among  CD62L
lo  population 
was ∼3：7 (Fig. 6A). At various time points after adoptive 
transfer, CD62L
hi donor cells gave rise to 1.2-fold higher lev-
els of surviving memory cells in peripheral blood (Fig. 6B). 
At  day  32  after  transfer,  CD62L
hi  donor  cells  increased  to 
2-fold higher levels in lymph nodes, compared with CD62L
lo 
donor cells, while there was no significant difference between 
CD62L
hi c e l l s  a n d  C D 6 2 L
lo  cells  in  other  tissues  including 
spleen, lung and liver (Fig. 6C). These data demonstrate that 
the enhanced survival of IL-12-primed CD43
lo CD8 T cells is 
partly  associated  with  CD62L  expression.
DISCUSSION
Despite  progress  over  the  last  few  years  in  elucidating  the 
mechanisms of memory cell development in T cell immunity, 
it is still not well understood. The presence of proinflamma-
tory cytokines in addition to TCR and costimulatory signals 
can  have  a  profound  effect  on  the  outcome  of  immune 
responses. Our previous study suggests that initial IL-12 sig-
naling strongly influences the programming of memory T cell 
development (9). In this study, we have identified a new sur-
face marker, CD43, the expression of which is regulated by 
initial IL-12 signaling. CD43 expression was previously shown 
to be a marker that distinguishes between memory and effec-
tor  T cells (18,20,35). Expression of CD43 is relatively low 
on naive CD8 T cells but high on Ag-specific effector CD8 
T cells, and becomes reduced again on Ag-specific memory 
CD8 T cells (20). Our data indicate that expression of the acti-
vated form of CD43 (1B11) is down-regulated by IL-12 pri-
ming  (Fig.  1A),  and  all  adoptively  transferred  CD43
lo a n d  
CD43
hi cells eventually changed into CD43
lo cells in the recip-
ient  mice.  But  these  antigen-specific  CD8  T  cells  exhibited 
CD43
hi  phenotype  again  when  they  met  the  same  antigen 
(data not shown). What are the functional consequences of 
the changes in CD43 expression on activated T cells? Recent 
studies  suggest  that  activation  markers  such  as  CD27  and 
CD43 define three distinct subpopulations of memory CD8 T 
cells that differ in their capacities to mount a recall response 
(37).  By  adoptively  transferring  purified  CD43
hi an d CD 43
lo 
T cells, we have shown that CD43
lo cells induced by IL-12 
priming have enhanced survival (Fig. 2B) and mediate stron-
ger recall responses (Fig. 5). Although all adoptively trans-
ferred CD43
lo and CD43
hi cells eventually turned into CD43
lo 
cells in recipient mice, the CD43
lo subset showed higher sur-
vival and recall potential than CD43
hi subset. In addition, we 
found a strong correlation between decreased expression of 
CD43 on antigen-specific CD8
＋ T cells and decreased func-
t i o n s  s u c h  a s  g r a n z y m e  B ,  c y t o l y t i c  a c t i v i t y  a n d  I F N - γ 
s ec re t io n.  U nt il  n ow ,  t he  e x ac t  ro le  o f CD 4 3 ha s n ot  b e en 
well defined due to its seemingly contradictory roles in sev-
eral  processes  such  as  cell  adhesion  and  costimulation 
(20,22,35,45). Our results support the idea that CD43 is pro-
miscuously related to T cell activation, effector functions, sur-
vival and recall responses but not T cell homing. The pre-
vious works have shown that TCR signaling leads to the redis-The Role of CD43 in CD8 T-cell Survival
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Figure 6. Enhanced survival of CD43
lo cells is partly associated with CD62L expression. (A) OT-I cells were cultured for 7 days with OVAp 
in the presence of IL-12. After 7 days, purified CD8
＋CD62L
hi T cells and CD8
＋CD62L
lo T cells were adoptively transferred into C57BL/6 mice.
(B) At the indicated time points, donor cell recovery from the peripheral blood of recipient mice was determined by tetramer staining, and (C)
on day 32, the frequency of donor OT-I cells in lymphoid and non-lymphoid organs of the recipient mice was measured.
tribution of CD43 outside of the mature immunological syn-
apse, and that relocalization of CD43 is required for optimal 
T cell activation (29,46). In addition, CD43 appears to provide 
intracellular signals that synergize with those of the TCR (47). 
These previous reports and our results both support the idea 
that CD43
hi cells have both TCR and CD43 signals at the same 
time, consequently CD43
hi cells, which have a stronger signal, 
may  exhibit  more  effector  function  than  CD43
lo c e l l s .  T h e  The Role of CD43 in CD8 T-cell Survival
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progressive  T  cell  activation  model  proposes  that  signal 
strength regulates the progression of the T cell through the 
hierarchy of proliferation, differentiation and death (7). Thus, 
it is likely that down-regulation of CD43 by IL-12 priming di-
minishes the overall strength of T cell stimulation, which pro-
vides a distinct advantage for the survival of activated CD8 
T  cells.
  In summary, the data presented here suggest that the effect 
of IL-12 priming on the prolonged survival of activated CD8 
T cell is mediated by down-regulation of CD43 expression. 
And decreased expression of CD43 has the potential to regu-
late generation and survival of effector/memory CD8
＋ T cell. 
Although further studies are needed to characterize the exact 
mechanisms of CD43 in the generation of memory CD8
＋ T 
cells,  our  findings  suggest  that  a  decreased  expression  of 
CD43 on activated CD8
＋ T cells by IL-12 priming is involved 
with  enhanced  generation  of  central  memory  precursors.
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